Wayne Forrest[email protected]Clinical NewsHybrid modalities disappoint in bone metastases accuracyDespite the apparent technological advantages of SPECT/CT, PET/CT, and PET/MRI, the three hybrid modalities do not perform appreciably better than planar bone scintigraphy in detecting and diagnosing bone metastases, according to a study published online on 10 August in the Journal of Nuclear Medicine.August 24, 2017Clinical NewsJAMA: PET best option to diagnose ischemic heart diseaseA head-to-head comparison to determine the most accurate modality for diagnosing myocardial ischemia has found that PET outperforms SPECT, coronary CT angiography, and hybrid variations of the three modalities in patients with suspected coronary artery disease, according to a study published online August 16 in JAMA Cardiology.August 20, 2017Clinical NewsPET is center of attention at U.K. Alzheimer's conferenceWhile PET can accurately detect or exclude Alzheimer's disease by imaging beta-amyloid plaques in the brain, the modality is underutilized in clinical care, according to research presented this week at the Alzheimer's Association International Conference in London.July 18, 2017Clinical NewsClinical success of 7T MRI requires only 'imagination'Most 7-tesla MRI scans have been devoted to the brain and neuroscience, but researchers in Berlin are focusing on the clinical potential of ultrahigh-field MR for cardiac applications. They're convinced the time is now for the game-changing technology.July 18, 2017Clinical NewsDWI-MRI shows vision changes could predict Parkinson'sWith the help of diffusion-weighted MR imaging (DWI-MRI), researchers in Italy have uncovered changes in the visual systems of patients newly diagnosed with Parkinson's disease, according to a study published online 11 July in Radiology.July 13, 2017Clinical NewsRadiotherapy boost based on PET not always helpfulSelectively increasing radiotherapy dose in tumor areas with significant uptake of the PET radiotracer F-18 fluoromisonidazole (FMISO) does not necessarily improve outcomes for non-small cell lung cancer patients, according to a phase II study published in the July issue of the Journal of Nuclear Medicine.July 12, 2017Molecular ImagingAuntMinnieEurope.com Molecular Imaging InsiderJuly 10, 2017NeuroradiologyDOPA-PET can alter brain tumor therapy decisionsThe use of the radiopharmaceutical fluorine-18 dihydroxyphenylalanine (F-18 DOPA) with PET imaging can lead to beneficial changes in management plans for patients with brain tumors, according to a study presented by French researchers at the recent Society of Nuclear Medicine and Molecular Imaging meeting.July 10, 2017Clinical NewsGerman team wins SNMMI Image of the Year awardThe U.S. Society of Nuclear Medicine and Molecular Imaging (SNMMI) on 14 June awarded its Image of the Year to German researchers who used PET/CT followed by fluorescence-guided surgery to demonstrate how dual-labeled prostate-specific membrane antigen (PSMA) inhibitors based on PSMA-11 enhance preoperative staging of metastatic prostate cancer.June 18, 2017Clinical NewsSNMMI Image of the Year awarded to German researchersDENVER - The Society of Nuclear Medicine and Molecular Imaging (SNMMI) on Wednesday awarded its Image of the Year to researchers who used PET/CT followed by fluorescence-guided surgery to demonstrate how dual-labeled prostate-specific membrane antigen (PSMA) inhibitors based on PSMA-11 enhance preoperative staging of metastatic prostate cancer.June 18, 2017Previous PagePage 17 of 46Next PageTop StoriesCTIR study: Keep aware of hydrophilic polymer embolizationClinicians, vendors, and regulators must collaborate to prevent hydrophilic polymer embolization, an underdiagnosed complication of endovascular interventions, European interventional radiology (IR) experts have asserted.CTRadiology mourns death of Ireland’s Barry KellyArtificial IntelligenceAI improves MRI diagnosis of prostate cancerMedical, Legal, and PracticeHow can we minimize errors caused by human factors?CTNew advice issued on cardiac CT for prosthetic heart valves